JACKSONVILLE BEACH, Fla.--(BUSINESS WIRE)--MedAxiom, the premier source for cardiovascular organizational performance solutions, has released the 2025 Cardiovascular Advanced Practice Provider (APP) Compensation and Utilization Report, which includes data from more than 100 provider organizations. The report features a foreword from Jerry Blackwell, MD, MBA, FACC, president and CEO of MedAxiom, highlighting APP contributions to productivity, workflow, access, and patient satisfaction, enabling.
OWINGS MILLS, MD, June 22, 2026 (GLOBE NEWSWIRE) -- The National Capital Chesapeake Bay Chapter of the National Academy of Television Arts & Sciences presented Maryland Public Television with 20 Emmys during its 68th Capital Emmy® Awards ceremony at the Bethesda North Marriott Hotel and Conference Center on Saturday, June 20. NATAS-NCCB comprises television industry professionals dedicated to fostering and recognizing outstanding achievements in television production in Maryland, Virginia, and Washington, D.C.
George Hill, Anguilla, 17 June 2026 -- As competition for medical school places in the United Kingdom reaches unprecedented levels, New Anglia University is providing aspiring doctors with an alternative pathway to medical education through its UK-aligned Doctor of Medicine (MD) programme, which combines an integrated curriculum with extensive NHS-based clinical rotations. The University's approach comes at a time when demand for medical school places continues to significantly exceed available capacity, leaving thousands of qualified applicants without a place each year despite strong academic credentials and a clear commitment to pursuing a career in medicine.
EINDHOVEN, Netherlands--(BUSINESS WIRE)-- #MedicalDevice--Onera Health, a leader in transforming sleep medicine, announces that its end-to-end home polysomnography solution, the Onera hPSG® solution, will be prominently featured in multiple scientific presentations at the forthcoming SLEEP 2026 conference. The medtech company will showcase this innovative solution at booth #600 during the largest annual sleep medicine conference, which brings together leading experts and innovators in the field. Furthermore, in.
BRISANE, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest” or “Tempest Therapeutics”) today announced the appointment of two independent directors, Drake Richey and John Yee, MD, MPH to its Board of Directors (the “Board”), effective [June 4, 2026]. Mr. Richey and Dr. Yee collectively bring decades of experience in corporate finance and therapeutic product development to the Board.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Announces Publication of New Research Addressing Urgent Questions in Neonatology.